ReviewDiscover oncology2025
Ferulic acid as a promising candidate for developing selective and effective anti-cancer therapies.
Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Updates on the Strategies to Improve the Anti-Tumor Efficacy of Ferulic Acid.International journal of molecular sciences · 2026Review
- Ferulic Acid Modulates High Glucose-Induced MMP-1/TIMP-1 Imbalance and Enhances Wound Closure of Human Gingival Fibroblasts.Biomedicines · 2026Article
- Panamanian Geisha Coffee Exhibits Antioxidant and Vasorelaxant Activities with a Favorable Safety Profile.Foods (Basel, Switzerland) · 2026Article
- Agro-Industrial Plant Biomass as a Sustainable Source of Anticancer Polyphenols: Molecular Mechanisms and Future Perspectives.Current issues in molecular biology · 2026Review
- Article
- Unifying Phytochemistry, Analytics, and Target Prediction to AdvanceLife (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCancer, a complex and rapidly advancing disease, stands as the second leading cause of death globally. Among the most frequently diagnosed cancers are breast, colon, lung, and prostate cancers. The incidence of these cancers has been rising sharply, a trend attributed partly to the insufficient effectiveness of current therapeutic drugs. This growing challenge has intensified the search for novel anti-cancer agents derived from natural sources.
methodsThis review covers the most recent literature on FA's anti-cancer properties. It provides an in-depth analysis of ferulic acid's impact on various cancer cell lines and the mechanisms of action.
resultsPlants are a rich reservoir of bioactive compounds that offer promising alternatives to synthetic drugs. Among these compounds, alkaloids, flavonoids, stilbenes, curcuminoids, and other phenolic substances have demonstrated significant free radical scavenging activity, suggesting their potential in various therapeutic applications. Ferulic acid (FA) is a hydroxycinnamic acid and phenolic compound found in different plants, fruits, vegetables, and grains. It occurs in exceptionally high concentrations in popcorn and bamboo shoots.
conclusionFA exhibits remarkable anti-inflammatory, antioxidant, and anti-cancer properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.